Below are links to the U.S. Food & Drug Administration’s (FDA) website for the most current legally-required licensing information published in manufacturer package inserts for influenza vaccines available in the U.S. It is important to understand and read this information carefully prior to receiving a vaccine. Vaccine product package inserts contain important information about ingredients, contraindications, precautions, reported adverse reactions, safety and effectiveness data from pre-licensure clinical trials, use recommendations and more.
Trivalent Vaccines – Nasal
- FluMist by MedImmune, LLC
Trivalent Vaccines – Injected
- AFLURIA by Seqirus Pty Ltd.
- Fluarix by GlaxoSmithKline Biologicals
- Flucelvax by Seqirus, Inc.
- FluLaval by ID Biomedical Corporation of Quebec
- Fluzone by Sanofi Pasteur Inc.
- Flublok by Protein Sciences Corporation
- FLUAD by Seqirus, Inc